CAAS Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,100
Closed -$224K – 1023
2022
Q1
$224K Sell
3,100
-900
-23% -$64.8K 0.01% 447
2021
Q4
$367K Buy
+4,000
New +$478K 0.01% 596
2021
Q1
– Sell
-1,500
Closed -$300K – 1390
2020
Q4
$300K Hold
1,500
– – ﹤0.01% 728
2020
Q3
$329K Sell
1,500
-34,800
-96% -$7.37M 0.01% 413
2020
Q2
$6.93M Buy
36,300
+26,800
+282% +$4.7M 0.23% 100
2020
Q1
$1.47M Buy
+9,500
New +$1.11M 0.15% 111

Other funds holding TDOC

CAAS Capital Management's TDOC Position: Q1 2022 in Review

CAAS Capital Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,288 shares — an estimated $165K sold.

CAAS Capital Management first reported a position in TDOC in Q4 2020 and held it in 5 quarters. The position peaked at $11.6M in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • CAAS Capital Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • CAAS Capital Management sold 2,288 Teladoc Health shares in Q1 2022, an estimated $165K.
  • CAAS Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 5 quarters.
  • CAAS Capital Management's Teladoc Health position peaked at $11.6M in Q1 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on CAAS Capital Management's 13F filing for Q1 2022, filed 13 May 2022.